Maintenance suppressive azole antifungal regimens are a major advance in controlling recurrent vulvovaginal candidiasis

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.20, Iss.7, 2004-07, pp. : 7-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Patients with Recurrent Vulvovaginal Candidiasis

By Sobel J.D.

Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. : 1059-1066

Adis International

Access to resources Recommend Favorite

Fluconazole in vulvovaginal candidiasis: control not cure

Inpharma, Vol. 1, Iss. 1453, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Posaconazole effective in azole-resistant mucosal candidiasis

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Fungicidal Activity of Azole Antifungal Agents

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 7, Iss. 2, 2008-04 ,pp. : 118-125

Bentham Science Publishers

Access to resources Recommend Favorite

Itraconazole and fluconazole are comparable for the treatment of acute vaginal or vulvovaginal candidiasis in nonpregnant women

Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite